Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression.

ABSTRACT:

SUBMITTER: Huang J 

PROVIDER: S-EPMC12728483 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature